NDAQFinance & insurancebusiness.nasdaq.com
| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $2.03B | $2.10B | $2.10B | $1.98B | $2.12B | $2.14B | $2.53B | $2.39B | ▲ +20.9% |
| Gross profit | $1.23B | $1.24B | $1.31B | $1.31B | $1.39B | $1.41B | $1.50B | $1.48B | ▲ +12.6% |
| Operating income | $517.00M | $547.00M | $568.00M | $586.00M | $630.00M | $657.00M | $712.00M | $732.00M | ▲ +24.9% |
| Net income | $355.00M | $395.00M | $452.00M | $423.00M | $518.00M | $519.00M | $507.00M | $540.00M | ▲ +27.7% |
| R&Dnever filed | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 0.68 $ | 0.78 $ | 0.73 $ | — | 0.91 $ | 0.89 $ | 0.96 $ | ▲ +31.5% |
| Margins (% of revenue) | |||||||||
| Gross | 60.4 % | 59.0 % | 62.2 % | 66.4 % | 65.5 % | 65.8 % | 59.2 % | 61.9 % | ▼ -4.6 pt |
| Operating | 25.4 % | 26.1 % | 27.0 % | 29.6 % | 29.7 % | 30.7 % | 28.1 % | 30.6 % | ▲ +1.0 pt |
| Net | 17.5 % | 18.8 % | 21.5 % | 21.4 % | 24.4 % | 24.3 % | 20.0 % | 22.6 % | ▲ +1.2 pt |
| Balance sheet | |||||||||
| Assets | $30.39B | $30.65B | $30.38B | $30.65B | $31.05B | $27.30B | $27.34B | $27.38B | ▼ -10.7% |
| Liabilities | $19.20B | $19.09B | $18.57B | $18.62B | $18.82B | $15.26B | $15.35B | $15.38B | ▼ -17.4% |
| Equity | $11.20B | $11.55B | $11.82B | $12.03B | $12.23B | $12.04B | $11.99B | $12.00B | ▼ -0.2% |
| Cash | $592.00M | $690.00M | $732.00M | $470.00M | $604.00M | $515.00M | $520.00M | $365.00M | ▼ -22.3% |
| Capital | |||||||||
| Shares outstanding | 575.15M | 574.12M | 573.80M | 571.00M | 568.44M | 565.54M | 558.98M | 554.96M | ▼ -2.8% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.